Sue-Jean Lin

CIK: 0001867788

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

STVN

Stevanato Group S.p.A.

Director

ARQT

Arcutis Biotherapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

ARQT
Arcutis Biotherapeutics, Inc.
Jun 15, 2026
Sale(S)
Direct
4.9K shares at avg. $24.38$121K
STVN
Stevanato Group S.p.A.
Jun 12, 2026
Award(A)
Direct
5K shares-
ARQT
Arcutis Biotherapeutics, Inc.
Jun 5, 2026
Award(A)
Direct
5.8K shares-
ARQT
Arcutis Biotherapeutics, Inc.
Nov 24, 2025
Exercise(M)
Direct
18.1K shares at avg. $8.63$156K
ARQT
Arcutis Biotherapeutics, Inc.
Nov 24, 2025
Exercise(M)
Direct
7.2K shares at avg. $7.51$54K
ARQT
Arcutis Biotherapeutics, Inc.
Nov 24, 2025
Sale(S)
Direct
25.3K shares at avg. $30.78$778K
ARQT
Arcutis Biotherapeutics, Inc.
Jun 12, 2025
Award(A)
Direct
7.6K shares-

		Type	Shares	Price		Ownership
Jun 15, 2026	ARQT Arcutis Biotherapeutics, Inc.	Sale(S)	4,946	$24.38	$120,587	Direct
Jun 12, 2026	STVN Stevanato Group S.p.A.	Award(A)	4,975	-	$0	Direct
Jun 5, 2026	ARQT Arcutis Biotherapeutics, Inc.	Award(A)	5,778	-	$0	Direct
Nov 24, 2025	ARQT Arcutis Biotherapeutics, Inc.	Exercise(M)	18,052	$8.63	$155,789	Direct
Nov 24, 2025	ARQT Arcutis Biotherapeutics, Inc.	Exercise(M)	7,220	$7.51	$54,222	Direct
Nov 24, 2025	ARQT Arcutis Biotherapeutics, Inc.	Sale(S)	25,272	$30.78	$777,956	Direct
Jun 12, 2025	ARQT Arcutis Biotherapeutics, Inc.	Award(A)	7,609	-	-	Direct

1-7 of 7 transactions

About LIN SUE-JEAN

LIN SUE-JEAN (SEC CIK 0001867788) files insider reports with the SEC as Director of Stevanato Group S.p.A. (STVN) and Director of Arcutis Biotherapeutics, Inc. (ARQT).

Signal8 holds 6 ownership filings by LIN SUE-JEAN (1 Form 3, 5 Form 4), filed between Jun 16, 2025 and Jun 26, 2026. Those filings report 7 transactions, from Jun 12, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LIN SUE-JEAN's filings is in WESTLAKE VILLAGE, CA.

Recent filings by LIN SUE-JEAN

Jun 15, 2026: Open-market sale of ARQT shares (Form 4, code S).
Jun 12, 2026: Grant or award of STVN shares (Form 4, code A).
Jun 5, 2026: Grant or award of ARQT shares (Form 4, code A).
Nov 24, 2025: Option exercises of ARQT shares (2 lines, Form 4, code M).
Nov 24, 2025: Open-market sale of ARQT shares (Form 4, code S).

Other insiders filing for Stevanato Group S.p.A. (STVN)

Santel Luciano, Director
Dal Lago Marco, Chief Financial Officer
Magistretti Elisabetta, Director
Balachandran Madhavan, Director
MOREL DONALD E JR, Director
Stocchi Mauro

How to read Form 4 transaction codes